Association of plasminogen-activator inhibitor 1 (PAI-1) 4G/5G gene polymorphism with survival and chemotherapy-related vascular toxicity in non-seminomatous testicular cancer (TC) No significant ...
Patients with clinical stage I nonseminomatous germ cell tumors (NSGCTs) have been managed with surveillance, chemotherapy, or retroperitoneal lymphadenectomy (RPLND) with similar survival outcomes.
Please can you give a brief introduction to robotic RPLND and how this procedure has traditionally been performed? Robotic RPLND utilizes laparoscopy combined with robotic technology to perform ...
The appropriate integration of surgery and chemotherapy in the management of non-seminomatous germ-cell tumors (NSGCT) has resulted in overall survival rates of over 90% for all stages of the disease.
SAN FRANCISCO — Retroperitoneal lymph node dissection (RPLND) could potentially be a first-line option for men with stage II A/B testicular seminoma in order to reduce long-term toxicity and secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results